NNVC - NANOVIRICIDES, INC.
1.15
0.178 15.487%
Share volume: 946,033
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.97
0.18
0.18%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 02-14-2024 | 05-15-2024 | 01-07-2025 | 11-14-2024 | 02-14-2025 | 05-15-2025 | 11-14-2025 | 02-17-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 2.185 M | 1.908 M | 2.391 M | 3.168 M | 2.059 M | 2.249 M | 1.797 M | 2.233 M | |
| Selling general and admin | 610.877 K | 693.742 K | 1.209 M | 1.235 M | 902.700 K | 966.905 K | 803.619 K | 1.115 M | |
| Research and development | 1.574 M | 1.215 M | 1.182 M | 1.933 M | 1.156 M | 1.282 M | 993.066 K | 1.119 M | |
| Total expenses | 2.185 M | 1.908 M | 2.391 M | 3.168 M | 2.059 M | 2.249 M | 1.797 M | 2.233 M | |
| -12.65% | 25.31% | 32.47% | -35.00% | 9.23% | -20.12% | 24.29% | |||
| Operating income | -2.185 M | -1.908 M | -2.391 M | -3.168 M | -2.059 M | -2.249 M | -1.797 M | -2.233 M | |
| Ebit | -2.102 M | -1.854 M | -2.356 M | -3.127 M | -2.027 M | -2.217 M | -1.785 M | -2.221 M | |
| Pretax income | -2.102 M | -1.854 M | -2.306 M | 0.000 | -2.027 M | -2.217 M | -1.785 M | -2.221 M | |
| -11.76% | 24.36% | -100.00% | inf% | 9.34% | -19.48% | 24.41% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.115 M | -1.854 M | -2.356 M | -3.127 M | -2.027 M | -2.217 M | -1.785 M | -2.221 M | |
| 12.32% | -27.04% | -32.72% | 35.16% | -9.34% | 19.48% | -24.41% |